Visceral fat area and cardiometabolic risk: The Kardiovize
study

J 2021

Visceral fat area and cardiometabolic risk: The Kardiovize study

POLCROVÁ, Anna, Iuliia PAVLOVSKA, Geraldo A. Maranhao NETO, Šárka KUNZOVÁ, Maria M. INFANTE-GARCIA et. al.

Základní údaje

Originální název

Visceral fat area and cardiometabolic risk: The Kardiovize study

Autoři

POLCROVÁ, Anna (203 Česká republika, garant, domácí), Iuliia PAVLOVSKA (804 Ukrajina, domácí), Geraldo A. Maranhao NETO (203 Česká republika), Šárka KUNZOVÁ (203 Česká republika), Maria M. INFANTE-GARCIA (862 Venezuela), Jose R. MEDINA-INOJOSA (840 Spojené státy), Francisco LOPEZ-JIMENEZ (840 Spojené státy), Jeffrey I. MECHANICK (840 Spojené státy), Ramfis NIETO-MARTINEZ (862 Venezuela), Gorazd Bernard STOKIN (203 Česká republika), Hynek PIKHART (203 Česká republika, domácí) a Juan P. GONZALEZ-RIVAS (840 Spojené státy)

Vydání

Obesity Research & Clinical Practice, OXFORD, ELSEVIER SCI LTD, 2021, 1871-403X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30308 Nutrition, Dietetics

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 5.214

Kód RIV

RIV/00216224:14310/21:00121420

Organizační jednotka

Přírodovědecká fakulta

DOI

http://dx.doi.org/10.1016/j.orcp.2021.03.005

UT WoS

000675529000010

Klíčová slova anglicky

Intra-abdominal fat; Cardiometabolic risk factors; Race factors

Štítky

14110525, podil

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 27. 1. 2022 22:15, Mgr. Michaela Hylsová, Ph.D.

Anotace

V originále

Background: Visceral fat is associated with adiposity-based complications. Bioimpedance measurement allows estimation of visceral fat area (VFA) in an easy manner. However, a validated cut-off value for VFA by bioimpedance associated with cardiometabolic risk is lacking in European population. Aim: To determine cut-off values of VFA measured via bioimpedance associated with cardiometabolic risk. Methods: Random cross-sectional Czech population-based sample of 25-64 years old subjects. Receiver Operating Characteristic (ROC) curves were used and the area under the curve (AUC), sensitivity, and specificity were calculated. The Cardiometabolic Disease Staging System (CMDS) was used to classify cardiometabolic risk: Stage 1 - 1 or 2 metabolic syndrome (MetS) components, without impaired fasting glucose (IFG); Stage 2 - MetS or IFG; Stage 3 - MetS with IFG; Stage 4 - type 2 diabetes and/or cardiovascular disease. Results: 2052 participants (54.5% females, median age 49 years) were included. Median VFA (inter-quartile range) were 82.2 cm(2) (54.8) in men and 89.8 cm(2) (55.6) in women. The best VFA cut-offs associated with Stage 1 in men and women were 71 cm(2)(sensitivity = 0.654; specificity = 0.427) and 83 cm(2) (sensitivity = 0.705; specificity = 0.556); Stage 2: 84 cm(2) (sensitivity = 0.673; specificity = 0.551) and 98 cm(2) (sensitivity = 0.702; specificity = 0.628); Stage 3: 90 cm(2) (sensitivity = 0.886; specificity = 0.605) and 109 cm(2) (sensitivity = 0.755; specificity = 0.704); Stage 4: 91 cm(2)(sensitivity = 0.625; specificity = 0.611) and 81cm(2) (sensitivity = 0.695; specificity = 0.448), respectively. Conclusion: A cut-off value of VFA of 71 cm(2) in men and 83 cm(2) in women exhibited the earliest stage of cardiometabolic risk, and 90 cm(2) in men and 109 cm(2) in women showed the best performance to detect risk.

Citovat

POLCROVÁ, Anna, Iuliia PAVLOVSKA, Geraldo A. Maranhao NETO, Šárka KUNZOVÁ, Maria M. INFANTE-GARCIA, Jose R. MEDINA-INOJOSA, Francisco LOPEZ-JIMENEZ, Jeffrey I. MECHANICK, Ramfis NIETO-MARTINEZ, Gorazd Bernard STOKIN, Hynek PIKHART a Juan P. GONZALEZ-RIVAS. Visceral fat area and cardiometabolic risk: The Kardiovize study. Obesity Research & Clinical Practice. OXFORD: ELSEVIER SCI LTD, 2021, roč. 15, č. 4, s. 368-374. ISSN 1871-403X. Dostupné z: https://dx.doi.org/10.1016/j.orcp.2021.03.005.

@article{1761318,
   author = {Polcrová, Anna and Pavlovska, Iuliia and Neto, Geraldo A. Maranhao and Kunzová, Šárka and InfanteandGarcia, Maria M. and MedinaandInojosa, Jose R. and LopezandJimenez, Francisco and Mechanick, Jeffrey I. and NietoandMartinez, Ramfis and Stokin, Gorazd Bernard and Pikhart, Hynek and GonzalezandRivas, Juan P.},
   article_location = {OXFORD},
   article_number = {4},
   doi = {http://dx.doi.org/10.1016/j.orcp.2021.03.005},
   keywords = {Intra-abdominal fat; Cardiometabolic risk factors; Race factors},
   language = {eng},
   issn = {1871-403X},
   journal = {Obesity Research & Clinical Practice},
   title = {Visceral fat area and cardiometabolic risk: The Kardiovize study},
   url = {https://www.sciencedirect.com/science/article/pii/S1871403X21000478?via%3Dihub},
   volume = {15},
   year = {2021}
}

TY  - JOUR
ID  - 1761318
AU  - Polcrová, Anna - Pavlovska, Iuliia - Neto, Geraldo A. Maranhao - Kunzová, Šárka - Infante-Garcia, Maria M. - Medina-Inojosa, Jose R. - Lopez-Jimenez, Francisco - Mechanick, Jeffrey I. - Nieto-Martinez, Ramfis - Stokin, Gorazd Bernard - Pikhart, Hynek - Gonzalez-Rivas, Juan P.
PY  - 2021
TI  - Visceral fat area and cardiometabolic risk: The Kardiovize study
JF  - Obesity Research & Clinical Practice
VL  - 15
IS  - 4
SP  - 368-374
EP  - 368-374
PB  - ELSEVIER SCI LTD
SN  - 1871403X
KW  - Intra-abdominal fat
KW  - Cardiometabolic risk factors
KW  - Race factors
UR  - https://www.sciencedirect.com/science/article/pii/S1871403X21000478?via%3Dihub
N2  - Background: Visceral fat is associated with adiposity-based complications. Bioimpedance measurement allows estimation of visceral fat area (VFA) in an easy manner. However, a validated cut-off value for VFA by bioimpedance associated with cardiometabolic risk is lacking in European population. Aim: To determine cut-off values of VFA measured via bioimpedance associated with cardiometabolic risk. Methods: Random cross-sectional Czech population-based sample of 25-64 years old subjects. Receiver Operating Characteristic (ROC) curves were used and the area under the curve (AUC), sensitivity, and specificity were calculated. The Cardiometabolic Disease Staging System (CMDS) was used to classify cardiometabolic risk: Stage 1 - 1 or 2 metabolic syndrome (MetS) components, without impaired fasting glucose (IFG); Stage 2 - MetS or IFG; Stage 3 - MetS with IFG; Stage 4 - type 2 diabetes and/or cardiovascular disease. Results: 2052 participants (54.5% females, median age 49 years) were included. Median VFA (inter-quartile range) were 82.2 cm(2) (54.8) in men and 89.8 cm(2) (55.6) in women. The best VFA cut-offs associated with Stage 1 in men and women were 71 cm(2)(sensitivity = 0.654; specificity = 0.427) and 83 cm(2) (sensitivity = 0.705; specificity = 0.556); Stage 2: 84 cm(2) (sensitivity = 0.673; specificity = 0.551) and 98 cm(2) (sensitivity = 0.702; specificity = 0.628); Stage 3: 90 cm(2) (sensitivity = 0.886; specificity = 0.605) and 109 cm(2) (sensitivity = 0.755; specificity = 0.704); Stage 4: 91 cm(2)(sensitivity = 0.625; specificity = 0.611) and 81cm(2) (sensitivity = 0.695; specificity = 0.448), respectively. Conclusion: A cut-off value of VFA of 71 cm(2) in men and 83 cm(2) in women exhibited the earliest stage of cardiometabolic risk, and 90 cm(2) in men and 109 cm(2) in women showed the best performance to detect risk.
ER  -

POLCROVÁ, Anna, Iuliia PAVLOVSKA, Geraldo A. Maranhao NETO, Šárka KUNZOVÁ, Maria M. INFANTE-GARCIA, Jose R. MEDINA-INOJOSA, Francisco LOPEZ-JIMENEZ, Jeffrey I. MECHANICK, Ramfis NIETO-MARTINEZ, Gorazd Bernard STOKIN, Hynek PIKHART a Juan P. GONZALEZ-RIVAS. Visceral fat area and cardiometabolic risk: The Kardiovize study. \textit{Obesity Research \&{}amp; Clinical Practice}. OXFORD: ELSEVIER SCI LTD, 2021, roč.~15, č.~4, s.~368-374. ISSN~1871-403X. Dostupné z: https://dx.doi.org/10.1016/j.orcp.2021.03.005.

Podrobný výpis o publikaci